Sign in
WithdrawnNo phase

Predicting Risk for Post-polypectomy Colorectal Cancer

Key facts

Who runs it
Kaiser Permanente
Where
Oakland, United StatesSee the site
Trial code
Status
Withdrawn
Started
1 Sept 2022
Ended
31 Dec 2023
Type of study
Interventional
Treatments tested
  • Logistic regression risk model
Record updated
28 February 2023
Why it stopped
Alternative method of implementation, study not needed

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients are on the current colonoscopy pending list; excluding those who were fecal immunochemical test-positive, screening colonoscopies, had a colonoscopy in last 12 months or on a voluntary "pause" list
  • Hereditary colorectal cancer syndrome (e.g. Lynch syndrome)
  • Diagnostic, fecal immunochemical test -positive, or screening indication for colonoscopy

Where in United States

  • Kaiser Permanente Northern California, Division of ResearchOakland, United States

About the trial

What the trial wants to find out

This originated as an observational study of Kaiser Permanente Northern California (KPNC) patients with a history of adenoma diagnosed by colonoscopy who received a subsequent surveillance colonoscopy between 2014 and 2019. The original goal of the study was to develop a risk prediction model that would help identify patients at highest risk for a diagnosis of advanced neoplasia (colorectal cancer and/or advanced adenoma) at or within 6 months following their surveillance colonoscopy. Candidate predictors of interest included patient demographics, medical history, and details related to the index colonoscopy. The investigators are now at the implementation stage and applying the risk prediction model to patients awaiting surveillance colonoscopy at select KPNC service areas to help identify those at highest risk for colorectal cancer based on their risk scores.

The group in the trial

  • Use of risk prediction scoresTreatment being tested

    The prediction model is being used to identify patients who are at highest risk for colorectal cancer based on their risk scores.

    Treatment: Logistic regression risk model

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
28 February 2023